Neovascular Age-related Macular Degeneration
CRFB002A-MAX-IL-01
Approved other completed
Quick answer
Neovascular Age-related Macular Degeneration for Neovacular Age-related Macular Degeneration is a Approved program (other) at Novartis Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Novartis Pharmaceuticals
- Indication
- Neovacular Age-related Macular Degeneration
- Phase
- Approved
- Modality
- other
- Status
- completed